BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25553939)

  • 1. Radial versus femoral access for angioplasty of ST-segment elevation acute myocardial infarction with second-generation drug-eluting stents.
    Marti V; Brugaletta S; García-Picart J; Delgado G; Cequier A; Iñiguez A; Hernandez-Antolin R; Serruys P; Serra A; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 Jan; 68(1):47-53. PubMed ID: 25553939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial.
    Bernat I; Horak D; Stasek J; Mates M; Pesek J; Ostadal P; Hrabos V; Dusek J; Koza J; Sembera Z; Brtko M; Aschermann O; Smid M; Polansky P; Al Mawiri A; Vojacek J; Bis J; Costerousse O; Bertrand OF; Rokyta R
    J Am Coll Cardiol; 2014 Mar; 63(10):964-72. PubMed ID: 24211309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: results from the ALKK PCI registry.
    Bauer T; Hochadel M; Brachmann J; Schächinger V; Boekstegers P; Zrenner B; Zahn R; Zeymer U;
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S8-14. PubMed ID: 25945803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.
    Regueiro A; Fernández-Rodríguez D; Brugaletta S; Martín-Yuste V; Masotti M; Freixa X; Cequier Á; Íñiguez A; Serruys PW; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):382-9. PubMed ID: 25444377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial vs femoral access after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Thirty-day and one-year mortality results.
    Ruano-Ravina A; Aldama-López G; Cid-Álvarez B; Piñón-Esteban P; López-Otero D; Calviño-Santos R; Ocaranza-Sánchez R; Vázquez-González N; Trillo-Nouche R; López-Pardo E
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):871-8. PubMed ID: 24773994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radial versus femoral access is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction: an observational cohort study of 10,095 patients.
    Iqbal MB; Arujuna A; Ilsley C; Archbold A; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; Wragg A; MacCarthy P; Dalby M;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):456-64. PubMed ID: 24963013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.
    Valgimigli M; Gagnor A; Calabró P; Frigoli E; Leonardi S; Zaro T; Rubartelli P; Briguori C; Andò G; Repetto A; Limbruno U; Cortese B; Sganzerla P; Lupi A; Galli M; Colangelo S; Ierna S; Ausiello A; Presbitero P; Sardella G; Varbella F; Esposito G; Santarelli A; Tresoldi S; Nazzaro M; Zingarelli A; de Cesare N; Rigattieri S; Tosi P; Palmieri C; Brugaletta S; Rao SV; Heg D; Rothenbühler M; Vranckx P; Jüni P;
    Lancet; 2015 Jun; 385(9986):2465-76. PubMed ID: 25791214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials).
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Kirtane AJ; Palmerini T; Tarigopula M; McAndrew T; Lansky AJ; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Mar; 113(6):930-5. PubMed ID: 24440325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study.
    Romagnoli E; Biondi-Zoccai G; Sciahbasi A; Politi L; Rigattieri S; Pendenza G; Summaria F; Patrizi R; Borghi A; Di Russo C; Moretti C; Agostoni P; Loschiavo P; Lioy E; Sheiban I; Sangiorgi G
    J Am Coll Cardiol; 2012 Dec; 60(24):2481-9. PubMed ID: 22858390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation.
    Mehta SR; Jolly SS; Cairns J; Niemela K; Rao SV; Cheema AN; Steg PG; Cantor WJ; Džavík V; Budaj A; Rokoss M; Valentin V; Gao P; Yusuf S;
    J Am Coll Cardiol; 2012 Dec; 60(24):2490-9. PubMed ID: 23103036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
    Lee MS; Wolfe M; Stone GW
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral--a prospective, randomised clinical trial (OCEAN RACE).
    Kołtowski L; Filipiak KJ; Kochman J; Pietrasik A; Rdzanek A; Huczek Z; Scibisz A; Mazurek T; Opolski G
    Kardiol Pol; 2014; 72(7):604-11. PubMed ID: 24671918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial.
    Pellaton C; Cayla G; Silvain J; Zeymer U; Cohen M; Goldstein P; Huber K; Pollack C; Kerneis M; Collet JP; Vicaut E; Montalescot G;
    Am Heart J; 2015 Oct; 170(4):778-86. PubMed ID: 26386802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.